30 October 2019, Volume 29 Issue 10

The timing of surgery during neoadjuvant therapy for breast cancer

MAO Yan, WANG Haibo

2019, 29 (10): 761-766. doi: 10.19401/j.cnki.1007-3639.2019.10.001

Abstract ( 98) PDF (1124KB) ( 151 )

Experimental study on quinacrine inducing apoptosis in extranodal natural killer (NK)/T-cell lymphoma cells

YANG Xue,WU Yingli,XU Jie,TONG Jia,JING Bo,WANG Yingying,ZHU Qi

2019, 29 (10): 767-772. doi: 10.19401/j.cnki.1007-3639.2019.10.002

Abstract ( 41) PDF (1651KB) ( 47 )

Correlation between cancer cell stemness and glucose metabolism characteristics in hepatocellular carcinoma

LI Yihao, DAI Qian, WANG Beili, PAN Baishen, GUO Wei

2019, 29 (10): 773-779. doi: 10.19401/j.cnki.1007-3639.2019.10.003

Abstract ( 36) PDF (1789KB) ( 37 )

Screening of aberrant DNA methylation in papillary thyroid cancer

CAO Yiming, ZHU Yongxue

2019, 29 (10): 780-787. doi: 10.19401/j.cnki.1007-3639.2019.10.004

Abstract ( 37) PDF (1334KB) ( 16 )

The effect of miR-27a-3p on chemotherapy sensitivity in hepatocellular carcinoma cells and its mechanism

YANG Ying, YANG Zhifang, CAI Ceng, ZHANG Ruili, LU Pengfei, JIA Chunli, LI Zhipeng, MAO Rui, ZHANG Hua, BAO Yongxing

2019, 29 (10): 788-794. doi: 10.19401/j.cnki.1007-3639.2019.10.005

Abstract ( 40) PDF (3935KB) ( 28 )

The influence of PD-L1 rs2297136 polymorphism on the clinical outcomes of postoperative colorectal cancer patients receiving capecitabine-based adjuvant chemotherapy

ZHANG Huijian,LIU Dianwen,ZHOU Xiaoli,LIU Yonggang,LI Min,LIU Shiju

2019, 29 (10): 795-802. doi: 10.19401/j.cnki.1007-3639.2019.10.006

Abstract ( 29) PDF (1291KB) ( 17 )

The single-center analysis of the efficacy and safety of nivolumab monoclonal antibody in advanced non-small cell lung cancer

LI Jingwen, ZHOU Yan, CAO Shuhui, WANG Yue, ZHONG Hua

2019, 29 (10): 803-808. doi: 10.19401/j.cnki.1007-3639.2019.10.007

Abstract ( 34) PDF (1393KB) ( 27 )

Clinical efficacy of osimertinib in the treatment of 62 patients with advanced lung adenocarcinoma

GAO Zhiqiang,WANG Weimin,CAI Yuqing,QIN Ruoyan,GU Aiqin,XIONG Liwen,HAN Baohui,JIANG Liyan,SHI Chunlei

2019, 29 (10): 809-814. doi: 10.19401/j.cnki.1007-3639.2019.10.008

Abstract ( 21) PDF (1105KB) ( 16 )

Application of radiomics signature captured from CT to predicting brain metastases in stage Ⅲ/Ⅳ anaplastic lymphoma kinase-positive non-small cell lung cancer patients

XU Xinyan, CHEN Jiayan, HUANG Lü, WANG Jiazhou, LIU Di,WEN Junmiao, CAO Jianzhao, FAN Min

2019, 29 (10): 815-823. doi: 10.19401/j.cnki.1007-3639.2019.10.009

Abstract ( 30) PDF (1605KB) ( 13 )

Advances in molecular targeted therapies for soft tissue sarcomas

LUO Chunli, LI Zhiping

2019, 29 (10): 824-831. doi: 10.19401/j.cnki.1007-3639.2019.10.010

Abstract ( 44) PDF (1104KB) ( 55 )

Notice More...
  • 2019-11-20
  • 2016-06-30
中国癌症杂志
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • The Western Pacific Region Index Medicus (WPRIM)
  • Chemical Abstracts

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHEN Zhenzhou

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat